Age: 27
Free Agency: 2029 (Void)
Accrued Seasons: 5
- Height: 6'5"
- Weight: 312
- College: Wisconsin
- Entry: 2021 Draft, Round 6, #214 overall (Packers)
- 2025 Salary Cap Charge: $4,606,000 (1.55% of cap)
- 2025 Cash Payout: $9,406,000 (2.97% of spending)
- 2025 Cash to Cap Ratio: 2.04
- Contract Value: $51,000,000 ($17,000,000 APY)
- Fully Guaranteed Money: $25,000,000
- Contract Ranking: 17/121 at LT
Current Contract
(Extension, signed 2025)
(📝: indicates contract trigger occuring during that year)| Year | Age | Base Salary | Prorated Bonus | Per Game Roster Bonus | Workout Bonus | Guaranteed Salary | Cap Number | Cap % | Dead Money & Cap Savings | |||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Signing | Option | |||||||||||||
| 2025 | 27 | $3,406,000 | $1,200,000 | $0 | $0 | $0 | $0 | $4,606,000 | 1.5% | |||||
| 2026
March 15: $7.5 million of 2027 salary is guaranteed
| 28 | $1,250,000 | $1,200,000 | $2,000,000 | $250,000 | $500,000 | $11,250,000 | $5,185,294 | 1.7% | |||||
| 2027 | 29 | $15,250,000 | $1,200,000 | $2,000,000 | $250,000 | $500,000 | $7,750,000 | $19,200,000 | 6.2% | |||||
| 2028 | 30 | $16,250,000 | $1,200,000 | $2,000,000 | $250,000 | $500,000 | $0 | $20,200,000 | 6.2% | |||||
| 2029 | 31 | Void | $1,200,000 | $2,000,000 | Void | Void | Void | $5,200,000 | -- | |||||
| 2030 | 32 | Void | $0 | $2,000,000 | Void | Void | Void | $0 | -- | |||||
| Total | $36,156,000 | $6,000,000 | $10,000,000 | $750,000 | $1,500,000 | $19,000,000 | $54,391,294 | |||||||
Contract Notes
Cole Van Lanen signed a three year, $51 million contract extension with the Jaguars on January 3, 2026. Van Lanen received $32.5 million in guarantees of which $25 million is fully guaranteed at signing. Van Lanen received a $6 million signing bonus and his 2026 salary and a $10 million option for 2026 are also fully guaranteed. $7.75 million of his 2027 salary is fully guaranteed while another $7.5 million will become fully guaranteed if on the roster on the 5th day of the 2026 league year. The contract has annual per game and workout bonuses and includes two void years for salary cap purposes.
Cash Flows
| 2025 | 2026 | 2027 | 2028 | |
|---|---|---|---|---|
| Cash Due | $6,000,000 | $12,000,000 | $16,000,000 | $17,000,000 |
| Running Cash | $6,000,000 | $18,000,000 | $34,000,000 | $51,000,000 |
Career Earnings: $16,033,692
Career APY: $3,206,738
Contract History
| Team | Contract Type | Status | Year Signed | Yrs | Total | APY | Guarantees | Amount Earned | % Earned | Effective APY |
|---|---|---|---|---|---|---|---|---|---|---|
| Packers | Drafted | Terminated | 2021 | 4 | $3,633,688 | $908,422 | $153,691 | $0 | 0.0% | $0 |
| Packers | Practice | Elevated | 2021 | 1 | $165,600 | $165,600 | $0 | $0 | 0.0% | $0 |
| Packers | Practice | Expired | 2021 | 1 | $193,067 | $193,067 | $0 | $248,001 | 128.5% | $248,001 |
| Packers | SFA | Traded | 2022 | 1 | $825,000 | $825,000 | $0 | $0 | 0.0% | $0 |
| Jaguars | SFA | Expired | 2022 | 1 | $825,000 | $825,000 | $0 | $825,000 | 100.0% | $825,000 |
| Jaguars | ERFA | Expired | 2023 | 1 | $940,000 | $940,000 | $0 | $940,000 | 100.0% | $940,000 |
| Jaguars | ERFA | Expired | 2024 | 1 | $1,055,000 | $1,055,000 | $0 | $1,055,000 | 100.0% | $1,055,000 |
| Jaguars | RFA | Active | 2025 | 1 | $3,406,000 | $3,406,000 | $0 | $3,406,000 | 100.0% | $3,406,000 |
| Jaguars | Extension | Active | 2025 | 3 | $51,000,000 | $17,000,000 | $25,000,000 | $9,406,000 | 18.4% | $9,406,000 |
Earnings By Team
| Team | Yrs | Salary | APY | Paid on Cap | % Paid on Cap | Paid as Dead Money | % Paid as Dead Money |
|---|---|---|---|---|---|---|---|
| Packers | 1 | $401,692 | $401,692 | $248,001 | 0.0% | $153,688 | 0.0% |
| Jaguars | 5 | $15,632,000 | $3,126,400 | $10,832,000 | 0.0% | $0 | 0.0% |
Season History
| Year | Team | Base Salary | Prorated Bonus | Option Bonus | Per Game Roster Bonus | Workout Bonus | Guaranteed Salary | Cap Number | Cap % | Cash Paid | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2021 | Packers | $165,600 | $0 | $0 | $0 | $0 | $0 | $248,001 | 0.1% | $248,001 | ||
| 2022 | Jaguars | $825,000 | $0 | $0 | $0 | $0 | $0 | $825,000 | 0.4% | $825,000 | ||
| 2023 | Jaguars | $940,000 | $0 | $0 | $0 | $0 | $0 | $940,000 | 0.4% | $940,000 | ||
| 2024 | Jaguars | $1,055,000 | $0 | $0 | $0 | $0 | $0 | $1,055,000 | 0.4% | $1,055,000 | ||
| 2025 | Jaguars | $3,406,000 | $1,200,000 | $0 | $0 | $0 | $0 | $4,606,000 | 1.5% | $9,406,000 | ||
| 2026 | Jaguars | $1,250,000 | $1,200,000 | $2,000,000 | $250,000 | $500,000 | $11,250,000 | $5,185,294 | 1.7% | $12,000,000 | ||
| 2027 | Jaguars | $15,250,000 | $1,200,000 | $2,000,000 | $250,000 | $500,000 | $7,750,000 | $19,200,000 | 6.2% | $16,000,000 | ||
| 2028 | Jaguars | $16,250,000 | $1,200,000 | $2,000,000 | $250,000 | $500,000 | $0 | $20,200,000 | 6.2% | $17,000,000 | ||
| 2029 | Jaguars | $17,000,000 | $1,200,000 | $2,000,000 | $0 | $0 | $0 | $5,200,000 | -- | $0 | ||
| 2030 | Jaguars | $17,000,000 | $0 | $2,000,000 | $0 | $0 | $0 | $0 | -- | $0 | ||
| Total | $76,547,600 | $6,000,000 | $10,000,000 | $750,000 | $1,500,000 | $19,000,000 | $60,865,295 | $60,880,001 | ||||
Statistics
| Year | Games Played | Games Inactive | Snaps | |
|---|---|---|---|---|
| Offense | Special | |||
| 2021 | 1 | 0 | 0.1% | 0.0% |
| 2023 | 9 | 7 | 4.5% | 7.2% |
| 2024 | 9 | 8 | 24.4% | 5.2% |
| 2025 | 16 | 1 | 55.0% | 16.6% |
Valuation Diamond
The diamond is a scatterplot graph that visualizes the relation of the player's APY (in green) and performance (in blue, as measured by OTC's Valuations) to the rest of the league at his position. To understand how to read the diamond, read this explainer.
| OTC Valuation | APY | |
|---|---|---|
| Regular | $4,804,000 | $3,406,000 |
| Injury Adjusted | $4,804,000 | $3,406,000 |
Weekly Valuation Trends
The chart below illustrates the trend of the player's weekly OTC Valuations (in blue) from the most recent season, using APY (in green) and, if applicable, cash that is due to the player in the next season (in red) as benchmarks. Weeks not plotted indicate that the player was inactive or on a bye.
To see interactive and more in-depth use of OTC Valuation data, subscribe to OTC Premium.